Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danazol for pulmonary fibrosis
NL-OMON44571Recruiting
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Aug 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of danazol in idiopathic pulmonary fibrosis (IPF) and pulmonary fibrosis (PF), sponsored by St. Antonius Ziekenhuis. Primary endpoint: Difference in yearly decline in lung function before and after danazol. Started Aug 2018; status: recruiting.
02
Drugs
danazol
03
Conditions
idiopathic pulmonary fibrosis (IPF)pulmonary fibrosis (PF)
Beyond the preview
Go deeper on NL-OMON44571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44571.